The Alberta DNA Repair ConsortiumThe Alberta DNA Repair Consortium brings together a group of discovery, translation, and clinical researchers from the Universities of Alberta, Calgary, and Lethbridge with the aim of improving the effectiveness of cancer treatment by exploiting our understanding of how damaged DNA is repaired.
The Health Problem
In 2015, an estimated 25000 Canadians will be diagnosed with colorectal cancer and approximately 9000 will die from the disease, accounting for 12% of all cancer deaths.
- Death from the Disease 36%
- Percentage of Colorectal Cancer Deaths 12%
For the group of patients with advanced disease, treatment relieves symptoms and maintains quality of life, but median survival is only 24-30 months after treatment. Even a small improvement in therapy in this very common cancer could transform many patient lives.
The Alberta DNA Repair Consortium brings together a group of discovery,
Our first initiative is focused on improving survival in colorectal cancer patients. Our team of researchers and cancer physicians has already developed some promising new targets and drugs for improving colorectal cancer treatments. We are building a ‘pipeline’ of new options to be tested first in the lab and then in patients. Our ultimate goal with all new treatment options is longer patient survival and a higher number of cured cancer patients.